Terug
Dagbereik
€ 34,18
€ 36,70
52-Weeksbereik
€ 28,53
€ 56,22
Volume
2.344.557
50D / 200D Gem.
€ 42,01
/
€ 40,00
Vorige Slotkoers
€ 34,86
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -633,8 | 0,3 |
| P/B | 2,2 | 2,9 |
| ROE % | -0,4 | 3,7 |
| Net Margin % | -0,3 | 3,8 |
| Rev Growth 5Y % | 9,2 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 52,13
+45.6%
Low: € 35,00
High: € 60,00
Forward K/W
16,5
Forward WPA
€ 2,12
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,6 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 3,40
€ 3,35 – € 3,44
|
4,2 B | 1 |
| FY2029 |
€ 3,11
€ 3,07 – € 3,15
|
4,2 B | 1 |
| FY2028 |
€ 2,77
€ 2,73 – € 2,80
|
3,9 B | 1 |
Belangrijkste Punten
Revenue grew 9,19% annually over 5 years — modest growth
Earnings declined -107,60% over the past year
Generating 43,30M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,11%
Capital efficient — spends only 2,64% of revenue on capex
ROIC of 3,61% — low return on invested capital
Groei
Revenue Growth (5Y)
9,19%
Revenue (1Y)2,08%
Earnings (1Y)-107,60%
FCF Growth (3Y)-57,80%
Kwaliteit
Return on Equity
-0,41%
ROIC3,61%
Net Margin-0,25%
Op. Margin6,30%
Veiligheid
Debt / Equity
0,83
Current Ratio1,73
Interest Coverage4,69
Waardering
P/E Ratio
-633,83
P/B Ratio2,22
EV/EBITDA33,22
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2,08% | Revenue Growth (3Y) | 7,67% |
| Earnings Growth (1Y) | -107,60% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 9,19% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3,44B | Net Income (TTM) | -8,60M |
| ROE | -0,41% | ROA | -0,14% |
| Gross Margin | 45,61% | Operating Margin | 6,30% |
| Net Margin | -0,25% | Free Cash Flow (TTM) | 43,30M |
| ROIC | 3,61% | FCF Growth (3Y) | -57,80% |
| Safety | |||
| Debt / Equity | 0,83 | Current Ratio | 1,73 |
| Interest Coverage | 4,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -633,83 | P/B Ratio | 2,22 |
| P/S Ratio | 1,59 | PEG Ratio | 6,94 |
| EV/EBITDA | 33,22 | Dividend Yield | 0,00% |
| Market Cap | 5,45B | Enterprise Value | 7,20B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,44B | 3,37B | 2,96B | 2,53B | 2,42B |
| Net Income | -8,60M | 113,10M | 427,20M | 296,60M | 277,10M |
| EPS (Diluted) | -0,15 | 0,76 | 2,90 | 1,99 | 1,81 |
| Gross Profit | 1,57B | 1,65B | 1,51B | 1,31B | 1,21B |
| Operating Income | 216,60M | 253,10M | 436,90M | 432,70M | 413,30M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 6,24B | 5,81B | 4,25B | 3,61B | 3,65B |
| Total Liabilities | 3,73B | 3,99B | 2,84B | 2,48B | 2,57B |
| Shareholders' Equity | 2,46B | 1,78B | 1,38B | 1,11B | 1,07B |
| Total Debt | 2,04B | 2,25B | 1,38B | 1,27B | 1,39B |
| Cash & Equivalents | 298,80M | 183,40M | 488,30M | 645,50M | 1,07B |
| Current Assets | 2,21B | 2,05B | 2,16B | 2,11B | 2,47B |
| Current Liabilities | 1,28B | 1,28B | 1,20B | 914,30M | 938,50M |